|
Delayed
Nasdaq Stockholm
16:33:59 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.7640 SEK | +2.41% |
|
-4.38% | +4.80% |
| 08-25 | Isofol Medical gets a new fair value estimate of 1.70 kronor from Redeye | FW |
| 08-25 | Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 239M 23.82M 21.17M 19.76M 18.01M 33.96M 2.29B 34.28M 92.65M 1.17B 89.45M 87.5M 3.76B | P/E 2026 * |
-3.93x | P/E 2027 * | -24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 239M 23.82M 21.17M 19.76M 18.01M 33.96M 2.29B 34.28M 92.65M 1.17B 89.45M 87.5M 3.76B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 7.36x |
| Free-Float |
73.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ISOFOL | Delayed | |
Deutsche Boerse AG
| 5IU | Delayed | |
|
Boerse Muenchen
| 5IU | Real-time |
| 1 day | +2.41% | ||
| 1 week | -4.38% | ||
| Current month | +0.53% | ||
| 1 month | +4.80% | ||
| 3 months | -7.73% | ||
| 6 months | +18.08% | ||
| Current year | +4.80% |
| 1 week | 0.73 |  | 0.8 |
| 1 month | 0.7 | | 0.82 |
| Current year | 0.55 | | 0.99 |
| 1 year | 0.55 | | 0.99 |
| 3 years | 0.45 | | 4.88 |
| 5 years | 0.45 | | 14.44 |
| 10 years | 0.45 | | 33.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 74 | 09/01/2024 |
Margareta Hagman
DFI | Director of Finance/CFO | 60 | 13/08/2024 |
Roger Tell
CEO | Chief Executive Officer | 61 | 22/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Lars Erik Lind
CHM | Chairman | 85 | 01/07/2010 |
Alain Herrera
BRD | Director/Board Member | 76 | 01/01/2018 |
Sten Nilsson
BRD | Director/Board Member | 78 | 04/01/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/10/21 A | Sell | 58,767 | 0.0364% | |||
| 12/10/21 A | Sell | 58,767 | 0.0364% | |||
| 6/14/21 A | Others | Chief Financial Officer | 15,153 | 0.0145% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.41% | -4.38% | +1.26% | -11.37% | 23.82M | |
| +1.43% | -2.04% | +37.34% | +114.34% | 1,019B | |
| -0.52% | -6.36% | +35.34% | +62.06% | 617B | |
| -0.25% | -1.72% | +13.69% | +77.48% | 464B | |
| -2.64% | -4.85% | +59.32% | +36.56% | 356B | |
| +0.30% | -2.03% | +20.74% | +41.14% | 333B | |
| +0.14% | -3.72% | +10.47% | +33.99% | 267B | |
| -0.78% | -5.27% | -7.01% | +8.55% | 244B | |
| -0.50% | -3.91% | +36.60% | +51.57% | 218B | |
| -0.49% | -5.17% | +27.09% | +93.23% | 179B | |
| Average | -0.10% | -3.88% | +23.48% | +50.76% | 369.72B | |
| Weighted average by Cap. | -0.09% | -3.54% | +29.25% | +69.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 32.5M 3.24M 2.88M 2.69M 2.45M 4.62M 311M 4.66M 12.59M 159M 12.16M 11.89M 511M |
| Net income | -58.5M -5.83M -5.18M -4.83M -4.41M -8.31M -560M -8.39M -22.67M -286M -21.89M -21.41M -919M | -69.3M -6.91M -6.14M -5.73M -5.22M -9.84M -664M -9.94M -26.85M -339M -25.93M -25.36M -1.09B |
| Net Debt | - | - |
Employees
7
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | SEK 0.7640 | +2.41% | 184,266 |
| 02/10/26 | SEK 0.7460 | -0.53% | 233,509 |
| 01/10/26 | SEK 0.7500 | -1.32% | 213,041 |
| 30/09/26 | SEK 0.7600 | -2.56% | 119,434 |
| 29/09/26 | SEK 0.7800 | -2.38% | 52,386 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ISOFOL Stock
Select your edition
All financial news and data tailored to specific country editions
